Replimune Group Inc’s recently made public that its Chief Medical Officer Xynos Konstantinos unloaded Company’s shares for reported $0.12 million on Jun 07 ’24. In the deal valued at $7.50 per share,15,881 shares were sold. As a result of this transaction, Xynos Konstantinos now holds 117,131 shares worth roughly $1.12 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Astley-Sparke Philip sold 37,928 shares, generating $245,394 in total proceeds. Upon selling the shares at $6.47, the Executive Chairman now owns 1,487,350 shares.
Before that, Patel Sushil sold 20,194 shares. Replimune Group Inc shares valued at $130,655 were divested by the Chief Executive Officer at a price of $6.47 per share. As a result of the transaction, Patel Sushil now holds 212,014 shares, worth roughly $2.03 million.
A number of analysts have revised their coverage, including Piper Sandler’s analysts, who began to cover the stock in mid November with a ‘”an Overweight”‘ rating. BTIG Research started covering the stock on November 17, 2020. It rated REPL as “a Buy”.
Price Performance Review of REPL
On Friday, Replimune Group Inc [NASDAQ:REPL] saw its stock jump 1.38% to $9.58. Over the last five days, the stock has lost -5.15%. Replimune Group Inc shares have risen nearly 13.64% since the year began. Nevertheless, the stocks have fallen -49.47% over the past one year. While a 52-week high of $21.32 was reached on 07/16/24, a 52-week low of $4.92 was recorded on 05/29/24. SMA at 50 days reached $8.87, while 200 days put it at $8.54. A total of 0.6 million shares were traded, compared to the trading of 0.44 million shares in the previous session.
Levels Of Support And Resistance For REPL Stock
The 24-hour chart illustrates a support level at 9.30, which if violated will result in even more drops to 9.02. On the upside, there is a resistance level at 9.94. A further resistance level may holdings at 10.30. The Relative Strength Index (RSI) on the 14-day chart is 50.01, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.54, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.81%. Stochastics%K at 19.10% indicates the stock is a buying.
The most recent change occurred on November 02, 2020 when Jefferies began covering the stock and recommended ‘”a Buy”‘ rating along with a $67 price target.
